Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,200
Closed -$11K 5300
2021
Q4
$11K Buy
+1,200
New +$14.4K ﹤0.01% 3597
2019
Q4
Sell
-300
Closed -$4.43K 3968
2019
Q3
$3K Sell
300
-200
-40% -$3.29K ﹤0.01% 3265
2019
Q2
$9K Sell
500
-1,700
-77% -$36.4K ﹤0.01% 2722
2019
Q1
$46K Buy
2,200
+1,200
+120% +$21.9K ﹤0.01% 1482
2018
Q4
$20K Sell
1,000
-300
-23% -$9.38K ﹤0.01% 2098
2018
Q3
$47K Sell
1,300
-1,000
-43% -$43.6K ﹤0.01% 1640
2018
Q2
$115K Buy
2,300
+2,100
+1,050% +$92.5K 0.01% 1060
2018
Q1
$7K Buy
+200
New +$6.13K ﹤0.01% 3023
2017
Q3
Sell
-3,224
Closed -$54.2K 5830
2017
Q2
$54K Buy
3,224
+300
+10% +$4.04K ﹤0.01% 2414
2017
Q1
$30K Buy
2,924
+1,437
+97% +$14.7K ﹤0.01% 2888
2016
Q4
$13K Sell
1,487
-100
-6% -$862 ﹤0.01% 3889
2016
Q3
$14K Buy
+1,587
New +$12.9K ﹤0.01% 3780

Other funds holding AXGN

Cutler Group's AXGN Position: Q1 2022 in Review

Cutler Group sold out of Axogen (AXGN) in Q1 2022, closing a stake of 1,200 shares — an estimated $11K sold.

Cutler Group first reported a position in AXGN in Q3 2016 and held it in 12 quarters. The position peaked at $115K in Q2 2018. 132 funds tracked by Wall St. Rank hold AXGN as of Q1 2022.

  • Cutler Group reported no remaining Axogen position as of Q1 2022 after selling out during the quarter.
  • Cutler Group sold 1,200 Axogen shares in Q1 2022, an estimated $11K.
  • Cutler Group first reported a position in Axogen in Q3 2016 and held it in 12 quarters.
  • Cutler Group's Axogen position peaked at $115K in Q2 2018.
  • 132 funds tracked by Wall St. Rank held Axogen as of Q1 2022.

Based on Cutler Group's 13F filing for Q1 2022, filed 14 Apr 2022.